|View archived Awards, Honors & Grants|
BWH is recognized as leader in both patient care and research, with expertise in virtually every specialty of medicine and surgery, and research spanning from basic, to clinical and translational. The BWH medical preeminence dates back to 1832, and today that rich history in clinical care is coupled with its national leadership in quality improvement and patient safety initiatives and its dedication to educating and training the next generation of health care professionals. Through investigation and discovery conducted at its Biomedical Research Institute (BRI), BWH is an international leader in research on human diseases, involving more than 1,000 physician-investigators and renowned biomedical scientists and faculty supported by more than $640 M in funding.
For the past 20 years, BWH has earned a place on the U.S. News & World Report's Honor Roll of America's Best Hospitals. The physicians, researchers and staff at BWH are recognized for excellence across specialties, while as an institution, the hospital also receives numerous accolades as care provider, employer, and more.
Awards & Honors - Sep 24, 2012BWH Researchers Receive Grant to Study Parkinson’s Disease
Tim Bartels, MSc, PhD; Dennis Selkoe, MD
The BWH Department of Neurology's Tim Bartels, PhD, MSc, assistant scientist, and Dennis Selkoe, MD, senior neurologist, have received an International Research Grant from the Parkinson's Disease Foundation (PDF).
The PDF announced research grants for 13 novel projects this year that are designed to find the cause(s) of and a cure for Parkinson's disease. Each of this year's projects take a fresh look at Parkinson's disease science and have high potential to significantly advance the knowledge of Parkinson's.
Bartels and Selkoe have discovered that the natural shape of alpha-synuclein, a synuclein protein primarily found in neural tissue, is misunderstood. Using their PDF International Research grant, they plan to build on this discovery, creating a way to easily test the difference in shape between alpha-synuclein in healthy people and in people with Parkinson's disease. This discovery could lead to a useful way to diagnose Parkinson's disease and test new therapies.